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IMPORTANCE Soft drinks are frequently consumed, but whether this consumption is
associated with mortality risk is unknown and has been understudied in European
populations to date.
OBJECTIVE To examine the association between total, sugar-sweetened, and artificially
sweetened soft drink consumption and subsequent total and cause-specific mortality.
DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study involved
participants (n = 451 743 of the full cohort) in the European Prospective Investigation into
Cancer and Nutrition (EPIC), an ongoing, large multinational cohort of people from 10
European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway,
Spain, Sweden, and the United Kingdom), with participants recruited between January 1,
1992, and December 31, 2000. Excluded participants were those who reported cancer, heart
disease, stroke, or diabetes at baseline; those with implausible dietary intake data; and those
with missing soft drink consumption or follow-up information. Data analyses were performed
from February 1, 2018, to October 1, 2018.
EXPOSURE Consumption of total, sugar-sweetened, and artificially sweetened soft drinks.
MAIN OUTCOMES AND MEASURES Total mortality and cause-specific mortality. Hazard ratios
(HRs) and 95% CIs were estimated using multivariable Cox proportional hazards regression
models adjusted for other mortality risk factors.
RESULTS In total, 521 330 individuals were enrolled. Of this total, 451 743 (86.7%) were
included in the study, with a mean (SD) age of 50.8 (9.8) years and with 321 081 women
(71.1%). During a mean (range) follow-up of 16.4 (11.1 in Greece to 19.2 in France) years, 41 693
deaths occurred. Higher all-cause mortality was found among participants who consumed 2
or more glasses per day (vs consumers of <1 glass per month) of total soft drinks (hazard ratio
[HR], 1.17; 95% CI, 1.11-1.22; P < .001), sugar-sweetened soft drinks (HR, 1.08; 95% CI, 1.01-1.16;
P = .004), and artificially sweetened soft drinks (HR, 1.26; 95% CI, 1.16-1.35; P < .001).
Positive associations were also observed between artificially sweetened soft drinks and
deaths from circulatory diseases (2 glasses per day vs <1 glass per month; HR, 1.52; 95% CI,
1.30-1.78; P < .001) and between sugar-sweetened soft drinks and deaths from digestive
diseases (1 glass per day vs <1 glass per month; HR, 1.59; 95% CI, 1.24-2.05; P < .001).
CONCLUSIONS AND RELEVANCE This study found that consumption of total, sugar-sweetened,
and artificially sweetened soft drinks was positively associated with all-cause deaths in this
large European cohort; the results are supportive of public health campaigns aimed at limiting
the consumption of soft drinks.
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T he frequent consumption of sugar-sweetened soft drinksincreases energy intake, which can lead to weight gainand obesity.1-3 In 2010, the worldwide burden of adi-
posity-associated cardiovascular diseases, cancers, and type
2 diabetes associated with consumption of sugar-sweetened
soft drinks was estimated to be 184 000 deaths.4 Reformula-
tion of sugar-sweetened soft drinks, in which sugar is re-
placed with low- or no-calorie sweeteners, is being driven by
consumer awareness and fiscal instruments, such as taxes.5
Artificially sweetened soft drinks have few or no calories; how-
ever, their long-term physiological and health implications are
largely unknown.6-8
Whether regular consumption of soft drinks (total, sugar-
sweetened, or artificially sweetened) is associated with greater
all-cause and cause-specific mortality is uncertain, given that
inconsistent findings were reported from previous prospec-
tive studies.9,10 Recently, a joint analysis of the Health Profes-
sionals Follow-up Study (HPFS) and Nurses’ Health Study (NHS)
reported that a higher level of consumption of sugar-
sweetened and artificially sweetened beverages was associ-
ated with greater all-cause mortality in the United States.11 Simi-
larly, a positive association between artificially sweetened
beverage consumption and all-cause mortality among US-
based women was also reported by the Women’s Health Ini-
tiative Observational Study.12 Large-scale studies are re-
quired to examine the association between soft drink
consumption and health outcomes, in particular research based
in populations outside of the United States. To our knowl-
edge, a large-scale European-based analysis of soft drink con-
sumption and mortality outcomes has not been undertaken.
For cause-specific mortality, previous studies on soft drink
consumption and cardiovascular disease mortality have found
positive associations.11,13 However, whether these associa-
tions differed by type of circulatory diseases (eg, ischemic heart
disease and cerebrovascular diseases) is uncertain. Similarly,
scant data are available to date on mortality from other major
chronic conditions such as cancers, digestive diseases, and neu-
rodegenerative diseases.
We investigated the association of consuming total, sugar-
sweetened, and artificially sweetened soft drinks with total and
cause-specific mortality among participants in the European
Prospective Investigation into Cancer and Nutrition (EPIC), an
ongoing, large multinational cohort with more than 41 000 re-
corded deaths reported during the follow-up period.
Methods
Study Population
EPIC is a multicenter cohort of 521 330 participants who were
recruited between January 1, 1992, and December 31, 2000,
predominantly from the general populations of 10 European
countries (Denmark, France, Germany, Greece, Italy, the Neth-
erlands, Norway, Spain, Sweden, and the United Kingdom).14,15
Written informed consent was provided by all study partici-
pants. Ethical approval for this study was provided by the In-
ternational Agency for Research on Cancer and the institu-
tional review boards of the local participating EPIC centers.
For the current analysis, we excluded participants who at
baseline reported cancer (n = 22 537), heart disease (n = 12 619),
stroke (n = 3683), or diabetes (n = 12 461); participants in the
highest or lowest 1% of the distribution of the ratio between
energy intake to estimated energy requirement (ie, those with
implausible dietary intake data; n = 8828); and participants
with missing soft drink consumption or missing follow-up in-
formation (n = 9459). The final study cohort included 451 743
participants (130 662 [28.9%] men; 321 081 [71.1%] women).
Assessment of Exposure
Dietary intake was assessed during the baseline enrollment visit
(1992-2000) by country-specific instruments that were devel-
oped and validated within the various source populations in
EPIC.14,15 Self-administered questionnaires were used in all cen-
ters, except in Greece, Spain, and Ragusa (Italy), where data
were collected during personal interviews. In Malmö (Swe-
den), a combined semiquantitative food frequency question-
naire and 7-day dietary diary and diet interview was used. For
soft drink consumption, participants recorded the number of
glasses per month, week, or day; the structure of the ques-
tions varied somewhat by country and questionnaire. The di-
etary questionnaires for most countries collected informa-
tion on the frequency of consumption (per glass) of “low calorie
or diet fizzy soft drinks,” “fizzy soft drinks, eg cola, lemon-
ade,” and “fruit squash or cordial.” Soft drink consumption
(grams per day, which is roughly equivalent to the amount in
milliliters; 1 glass was equal to approximately 250 mL) was cal-
culated using typical glass sizes in each center.
Total soft drinks referred to a combination of soft drinks,
carbonated and isotonic drinks, and diluted syrups. Total soft
drink consumption was subdivided into sugar-sweetened and
artificially sweetened soft drink consumption for all coun-
tries except Italy, Spain, and Sweden, where types of soft drinks
were unmeasured. The reproducibility and validity of the di-
etary questionnaires were assessed in some countries,14-21 with
correlations between repeated dietary questionnaires and with
24-hour dietary records ranging from 0.46 to 0.77 for soft or
nonalcoholic drinks in the Netherlands, France, Germany, and
Spain. Lifestyle questionnaires, administered at recruitment,
were used as a source of information on educational attain-
ment, smoking habits, alcohol intake, physical activity, repro-
ductive and menstrual characteristics, and other variables.
Key Points
Question Is regular consumption of soft drinks associated with a
greater risk of all-cause and cause-specific mortality?
Findings In this population-based cohort study of 451 743
individuals from 10 countries in Europe, greater consumption of
total, sugar-sweetened, and artificially sweetened soft drinks was
associated with a higher risk of all-cause mortality. Consumption of
artificially sweetened soft drinks was positively associated with
deaths from circulatory diseases, and sugar-sweetened soft drinks
were associated with deaths from digestive diseases.
Meaning Results of this study appear to support ongoing public
health measures to reduce the consumption of soft drinks.
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Ascertainment of Deaths
Data on vital status as well as the cause and date of death were
collected by EPIC centers through record linkages with can-
cer registries, boards of health, and death indices in Den-
mark, Italy, the Netherlands, Norway, Spain, Sweden, and the
United Kingdom or through active follow-up (inquiries by mail
or telephone to municipal registries or regional health depart-
ments or to physicians or hospitals) in Germany, Greece, and
France. For the current study, follow-up of participants from
baseline (1992-2000) occurred from December 2009 to De-
cember 2013 for countries with record linkage. The end of fol-
low-up was considered to be the last known contact with par-
ticipants in France (June 2008), Germany (December 2009),
and Greece (December 2012). Loss to follow-up was relatively
low at 1.5%.
International Statistical Classification of Diseases and Re-
lated Health Problems, Tenth Revision (ICD-10) codes were used
to classify the underlying cause of death. Deaths were grouped
into common causes: cancer (ICD-10 codes C00-D48), circu-
latory diseases (ICD-10 codes I00-I99), and digestive dis-
eases (ICD-10 codes K00-K93). Additional specific causes were
breast cancer (ICD-10 code C50); colorectal cancer (ICD-10 code
C18-C20); prostate cancer (ICD-10 code C61); cerebrovascular
disease (ICD-10 codes I60-I69); ischemic heart disease (ICD-10
codes I20-I25); and the neurodegenerative diseases, Alzhei-
mer (ICD-10 code G30) and Parkinson (ICD-10 code G20).
Statistical Analysis
Hazard ratios (HRs) and 95% CIs for mortality were estimated
using Cox proportional hazards regression models with age as
the primary time metric. Time at study entry was age at recruit-
ment, and exit time was age at death or the last date at which
follow-up was considered complete in each EPIC center. Mod-
els were stratified by age at recruitment in 1-year categories, sex,
and EPIC center. Soft drink consumption was categorized by the
frequency of glasses consumed (<1 glass per month, 1 to 4 glasses
per month, >1 to 6 glasses per week, 1 to <2 glasses per day, or
≥2 glasses per day, with 1 glass being equal to 250 mL). Linear
trend tests across exposure groups were evaluated using the me-
dian category variables as continuous terms. Multivariable mod-
els were adjusted for alcohol consumption; smoking status, in-
tensity, and duration; body mass index (BMI) (calculated as
weight in kilograms divided by height in meters squared); physi-
cal activity; educational status; menopausal status; ever use of
menopausal hormone therapy; and dietary intakes of total en-
ergy, red and processed meats, coffee, fruit and vegetable juices,
and fruits and vegetables. Further adjustment for dietary fiber
intake resulted in virtually unchanged risk estimates, so this vari-
able was not included in the final multivariable models. Sugar-
sweetened and artificially sweetened soft drinks were also mu-
tually adjusted.
The association between soft drink consumption and mor-
tality was also assessed across subgroups of smoking status,
BMI, physical activity, and alcohol consumption. Tests for in-
teraction were performed with the likelihood ratio test of mod-
els with and without interaction terms. Heterogeneity across
countries was explored using a meta-analysis approach.22 We
further investigated the shape of the association between soft
drink consumption and all-cause mortality using restricted cu-
bic splines with knots defined by the midpoints of aforemen-
tioned categories. The proportional hazard assumption was sat-
isfied using Schoenfeld residuals23 analyses.
In sensitivity analyses, we excluded BMI from the multi-
variable models to assess the potential mediating role of adi-
posity for the association between soft drinks and mortality.
To investigate reverse causality, analyses were conducted ex-
cluding deaths within the first 8 years of follow-up. We exam-
ined the associations of sole consumption of sugar-
sweetened and artificially sweetened soft drinks with mortality.
In addition, we examined the associations between soft drink
consumption and mortality according to the death ascertain-
ment method (linkage or active follow-up), with nonconsum-
ers of soft drinks as the reference group, and with adjustment
of the multivariable models for the World Cancer Research
Fund dietary score24 (rather than individual dietary covari-
ates). As a negative control analysis, we also examined the as-
sociations between soft drink consumption and deaths from
external causes. All statistical tests were 2-sided, and P < .05
was considered statistically significant. Data analyses were per-
formed from February 1, 2018, to October 1, 2018.
Results
Patients and Characteristics
Of the EPIC cohort of 521 330 participants, 451 743 (86.7%) were
included in the study, among whom were 321 081 women (71.1%)
and 130 662 men (28.9%) with a mean (SD) age of 50.8 (9.8)
years. After a mean (range) follow-up of 16.4 (11.1 in Greece to
19.2 in France) years, 41 693 deaths (18 302 men and 23 391 wom-
en) were recorded. Of these deaths, 18 003 (43.2%) were from
cancers, 9106 (21.8%) from circulatory diseases, and 1213 (2.9%)
from digestive diseases. Compared with low consumers of soft
drinks (<1 glass per month, high consumers (≥2 glasses per day)
were younger (mean [IQR] age at recruitment, 52.2 [46.4-58.4]
years vs 50.5 [38.4-56.6] years), more likely to be current smok-
ers (46 154 [20.5%] vs 4706 [29.1%]), and more likely to be physi-
cally active (34 907 [15.5%] vs 4501 [27.8%]) (Table 1).
Soft Drink Consumption and Mortality
All-Cause Mortality
Higher all-cause mortality was found for participants who con-
sumed 2 or more glasses per day (vs consumers of <1 glass per
month) of total soft drinks (HR, 1.17; 95% CI, 1.11-1.22; P < .001),
sugar-sweetened soft drinks (HR, 1.08; 95% CI, 1.01-1.16;
P = .004), and artificially sweetened soft drinks (HR, 1.26; 95%
CI, 1.16-1.35; P < .001) (Table 2). Similar associations were found
for men and women (Table 2). Nonlinear J-shaped associa-
tions (nonlinear P < .001) were observed between all-cause
mortality and total, sugar-sweetened, and artificially sweet-
ened soft drinks, with higher risks observed at consumption
levels of more than 125 mL per day for artificially sweetened
soft drinks and more than 225 mL per day of sugar-
sweetened soft drinks (eFigure in the Supplement). Among par-
ticipants with a BMI lower than 25 (healthy weight), positive
associations with all-cause mortality were found for total soft
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drinks (≥1 glass per day vs <1 glass per month; HR, 1.18; 95%
CI, 1.11-1.25), sugar-sweetened soft drinks (HR, 1.11; 95% CI,
1.03-1.21), and artificially sweetened soft drinks (HR, 1.27; 95%
CI, 1.12-1.43) (Figure).
The soft drink consumption and all-cause mortality asso-
ciations were generally consistent across subgroups of other
mortality risk factors. For sugar-sweetened soft drinks, a posi-
tive association was found among participants with a BMI of
30 or higher (obese) but not among those with a BMI between
25 and under 30 (overweight) (HR, 1.23; 95% CI, 1.10-1.39 vs
HR, 0.98; 95% CI, 0.90-1.06; P = .002; Figure). Results re-
mained similar when country-specific estimates were pooled
in a random-effects meta-analysis (eTable 1 in the Supple-
ment). No heterogeneity across countries was found for arti-
ficially sweetened soft drinks and all-cause mortality (I2 = 0%;
P = .86); however, heterogeneity was detected for sugar-
sweetened soft drinks (I2 = 63%; P = .01), although positive as-
sociations were found for all but 1 country.
Soft Drink Consumption and Cause-Specific Mortality
Circulatory Diseases
Higher circulatory diseases mortality risk was found for par-
ticipants consuming 2 or more glasses per day (vs consumers
of <1 glass per month) of total soft drinks (HR, 1.27; 95% CI,
1.14-1.40; P < .001) and artificially sweetened soft drinks
(HR, 1.52; 95% CI, 1.30-1.78; P < .001) but not sugar-
sweetened soft drinks (HR, 1.11; 95% CI, 0.95-1.30; P = .16)
(Table 3). Similar results were found for men and women. Posi-
tive associations for ischemic heart disease mortality risk were
found for total soft drinks (≥1 glass per day vs <1 glass per
month; HR, 1.19; 95% CI, 1.06-1.33; P = .001) and artificially
sweetened soft drinks (HR, 1.41; 95% CI, 1.11-1.79; P = .003)
(Table 4), with no association for sugar-sweetened soft drinks.
Total soft drinks were positively associated with cerebrovas-
cular disease mortality risk (HR, 1.30; 95% CI, 1.12-1.50;
P < .001), with positive statistically nonsignificant associa-
tions found for sugar-sweetened and artificially sweetened soft
drinks (Table 4).
Cancer
Total, sugar-sweetened, and artificially sweetened soft drink
consumption was not associated with risk of deaths from over-
all cancer (Table 3), breast cancer, or prostate cancer (Table 4).
Total soft drink consumption was positively associated with
colorectal cancer deaths (≥1 glass per day vs <1 glass per month;
HR, 1.25; 95% CI, 1.07-1.47; P = .004) (Table 4), with statisti-
cally nonsignificant associations found for sugar-sweetened
and artificially sweetened soft drinks.
Digestive Diseases
Higher level of consumption of total soft drinks and sugar-
sweetened soft drinks (≥1 glass per day vs <1 glass per month;
Table 1. Baseline Characteristics of Participants
Variable
Soft Drink Consumption, Median (IQR)
Total Artificially Sweetened Sugar-Sweetened
<1 Glassa per mo ≥2 Glassesa per d <1 Glassa per mo ≥2 Glassesa per d <1 Glassa per mo ≥2 Glassesa per d
All participants, No. 225 543 16 200 246 065 6292 195 505 7402
All-cause deaths, No. 21 032 1869 22 789 737 17 685 831
Age at recruitment, y 52.2 (46.4-58.4) 50.5 (38.4-56.6) 52.1 (46.1-58.4) 51.2 (40.9-56.6) 52.2 (46.5-58.2) 50.7 (34.7-56.9)
Women, No. (%) 172 480 (76.5) 9864 (60.9) 184 656 (75.0) 4556 (72.4) 155 705 (79.6) 4278 (57.8)
BMI 24.4 (22.1-27.3) 25.5 (22.8-28.6) 24.1 (21.8-26.9) 26.1 (23.4-30.0) 24.0 (21.8-26.8) 24.7 (22.2-27.7)
Higher education (including
university), No. (%)
59 032 (26.2) 3211 (19.8) 69 713 (28.3) 1303 (20.7) 58 208 (29.8) 1555 (21.0)
Current smoker, No. (%) 46 154 (20.5) 4706 (29.1) 49 491 (20.1) 1623 (25.8) 37 203 (19.0) 2201 (29.7)
Physically active, No. (%)b 34 907 (15.5) 4501 (27.8) 43 357 (17.6) 1752 (27.8) 33 794 (17.3) 2237 (30.2)









Consumption, g per d
Red and processed meat 66.2 (38.4-99.5) 75.2 (34.3-117.3) 67.6 (38.6-101.7) 68.8 (26.3-109.6) 66.5 (37.2-100.7) 77.0 (28.7-122.8)










Alcohol 5.8 (0.9-16.6) 5.6 (1.1-14.1) 6.0 (1.3-15.8) 6.3 (1.4-15.1) 6.3 (1.4-16.2) 6.1 (1.3-14.3)









Fruit and vegetable juices 14.3 (0.0-85.7) 17.1 (1.7-100.1) 35.6 (3.4-106.3) 16.8 (1.7-94.3) 28.6 (1.7-104.3) 18.2 (3.4-107.3)
Ever-use of contraceptive pill,
No. (%)c
97 195 (56.4) 6781 (68.7) 111 871 (60.6) 3295 (72.3) 97 036 (62.3) 3021 (70.6)
Ever-use of menopausal
hormone therapy, No. (%)c
45 378 (26.3) 2462 (25.0) 51 889 (28.1) 1317 (28.9) 47 168 (30.3) 992 (23.2)
Postmenopausal, No. (%)c 78 158 (45.3) 3641 (36.9) 82 945 (44.9) 1730 (38.0) 70 066 (45.0) 1561 (36.5)
Abbreviation: IQR, interquartile range.
a 1 glass is equal to approximately 250 mL.
b Defined as those with a sedentary job with more than 1 hour of recreational
activity per day, a standing job with more than 30 minutes of recreational
activity per day, a physical job with at least some recreational activity, or a
heavy manual job.
c Presented for women only.
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HR, 1.59; 95% CI, 1.24-2.05; P < .001), but not artificially sweet-
ened soft drinks, was associated with digestive disease mor-
tality. Similar associations were found for men and women
(Table 3).
Neurodegenerative Diseases
Total soft drink consumption was positively associated with
risk of Parkinson disease mortality (≥1 glass per day vs <1
glass per month; HR, 1.59; 95% CI, 1.07-2.36; P = .02), with
similar magnitude nonsignificant associations found for
artificially sweetened and sugar-sweetened soft drinks
(Table 4). Soft drinks were not associated with Alzheimer
disease mortality.
Sensitivity Analyses
Sugar-sweetened and artificially sweetened soft drink con-
sumption was positively associated with circulatory disease
and digestive disease mortality among participants with a
healthy weight (eTable 2 in the Supplement). Similar posi-
tive associations between soft drink consumption and mor-
tality outcomes were found when the multivariable models
excluded BMI adjustment (eTable 3 in the Supplement),




Trend<1 Glassa per mo
1 to 4 Glassesa
per mo
>1 to 6 Glassesa
per wk
1 to <2 Glassesa
per d ≥2 Glassesa per d
Total Soft Drinks
Deaths, No. 21 032 5845 10 730 2217 1869 NA
Sexes combined
Basic modelb 1 [Reference] 0.95 (0.92-0.97) 0.98 (0.95-1.00) 1.16 (1.11-1.22) 1.26 (1.20-1.32) <.001
Multivariable modelc 1 [Reference] 0.97 (0.94-1.00) 0.98 (0.96-1.01) 1.10 (1.06-1.16) 1.17 (1.11-1.22) <.001
Men
Multivariable modelc 1 [Reference] 0.96 (0.92-1.00) 0.99 (0.95-1.02) 1.09 (1.03-1.17) 1.16 (1.09-1.24) <.001
Women
Multivariable modelc 1 [Reference] 0.97 (0.93-1.01) 0.98 (0.95-1.02) 1.12 (1.05-1.19) 1.16 (1.08-1.25) <.001
Artificially Sweetened Soft Drinkd
Deaths, No. 22 789 2679 2689 151 737 NA
Sexes combined
Basic modelb 1 [Reference] 0.92 (0.88-0.96) 1.01 (0.97-1.05) 1.09 (0.93-1.28) 1.35 (1.25-1.45) <.001
Multivariable modelc 1 [Reference] 0.93 (0.89-0.97) 1.01 (0.97-1.05) 0.99 (0.84-1.17) 1.26 (1.16-1.35) <.001
Men
Multivariable modelc 1 [Reference] 0.94 (0.88-1.00) 1.06 (0.99-1.13) 1.12 (0.86-1.44) 1.26 (1.12-1.41) <.001
Women
Multivariable modelc 1 [Reference] 0.93 (0.88-0.99) 0.97 (0.92-1.03) 0.92 (0.75-1.13) 1.24 (1.13-1.37) <.001
Sugar-Sweetened Soft Drinkd
Deaths, No. 17 685 4175 5420 934 831 NA
Sexes combined
Basic modelb 1 [Reference] 0.91 (0.88-0.95) 0.96 (0.93-1.00) 1.14 (1.07-1.23) 1.16 (1.08-1.25) <.001
Multivariable modelc 1 [Reference] 0.94 (0.91-0.98) 0.96 (0.93-1.00) 1.08 (1.01-1.16) 1.08 (1.01-1.16) .004
Men
Multivariable modelc 1 [Reference] 0.96 (0.91-1.01) 0.96 (0.91-1.01) 1.03 (0.93-1.13) 1.09 (0.99-1.20) .05
Women
Multivariable modelc 1 [Reference] 0.93 (0.89-0.98) 0.97 (0.93-1.01) 1.14 (1.04-1.25) 1.06 (0.95-1.18) .04
Abbreviations: HR, hazard ratio; NA, not applicable.
a One glass is equal to approximately 250 mL.
b Basic Cox regression model adjusted for total energy intake (kcal per day) and
stratified by age (1-year categories), EPIC (European Prospective Investigation
into Cancer and Nutrition) center, and sex.
c Multivariable Cox regression model adjusted for body mass index, calculated
as weight in kilograms divided by height in meters squared (<22, 22 to <25,
25 to <30, 30 to <35, or 35); physical activity index (inactive, moderately
inactive, moderately active, or active); educational status (none; primary
school completed; technical or professional school; secondary school; longer
education, including university; or not specified); alcohol consumption
(nonconsumer, <5, 5 to <15, 15 to <30, or 30 g per day); smoking status and
intensity (never; current: 1-15 cigarettes per day; current: 16-25 cigarettes per
day; current: 16 cigarettes per day; former: quit 10 y; former: quit 11-20 y;
former: quit 20 y; current: pipe, cigar, occasional; current or former: missing;
or unknown); smoking duration (<10, 10 to <20, 20 to <30, 30 to <40, 40 y,
or smoking duration unknown); ever use of contraceptive pill (yes, no, or
unknown); menopausal status (premenopausal, postmenopausal,
perimenopausal or unknown menopausal status, or surgical postmenopausal);
ever use of menopausal hormone therapy (yes, no, or unknown); and intakes
of total energy (kcal per day), red and processed meat (g per day), fruits and
vegetables (g per day), coffee (g per day), and fruit and vegetable juice
(g per day) (all continuous); and stratified by age (1-year categories), EPIC
center, and sex.
d Sugar-sweetened and artificially sweetened soft drinks were mutually
adjusted. Italy, Spain, and Sweden were excluded from these analyses because
information on type of soft drink consumption was not collected.
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deaths that occurred during the first 8 years of follow-up
were excluded (eTable 4 in the Supplement), nonconsumers
of soft drinks were set as the reference group (eTable 5 in
the Supplement), and multivariable models were adjusted
for the World Cancer Research Fund dietary score rather
than individual dietary covariates (eTable 6 in the Supple-
ment). A similar pattern of results for all mortality end
points was found for sole consumers of artificially sweet-
ened and sugar-sweetened soft drinks (eTable 7 in the
Supplement). The positive sugar-sweetened association was
stronger for countries with active follow-up, compared
with those with linkage follow-up (eTable 8 in the Supple-
ment). No associations were found between soft drink con-
sumption and deaths by external causes (eTable 9 in the
Supplement).
Discussion
In this large multinational European study, higher level of con-
sumption of total, sugar-sweetened, and artificially sweet-
ened soft drinks was associated with increased risk of death
from all causes. The positive association between soft drink
consumption and mortality was evident for both men and
women. Only artificially sweetened, and not sugar-
sweetened, soft drinks were associated with deaths from cir-
culatory diseases, whereas for digestive disease deaths, only
sugar-sweetened soft drinks were associated with higher risk.
The high level of consumption of sugar-sweetened and ar-
tificially sweetened soft drinks has previously been linked to
elevated risks of obesity, type 2 diabetes, and cardiovascular
Figure. Subgroup Analyses of the Association Between Soft Drink Consumption and All-Cause Mortality
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The hazard ratios (HRs) are for comparing participants who drank 1 glass per
day with those who had <1 glass per month. Multivariable Cox regression model
adjusted for body mass index (BMI), calculated as weight in kilograms divided
by height in meters squared (<22, 22 to <25, 25 to <30, 30 to <35, or 35);
physical activity index (inactive, moderately inactive, moderately active, or
active); educational status (none; primary school completed; technical or
professional school; secondary school; longer education, including university; or
not specified); alcohol consumption (nonconsumer, <5, 5 to <15, 15 to <30, or
30 g per day); smoking status and intensity (never; current: 1-15 cigarettes per
day; current: 16-25 cigarettes per day; current: 16 cigarettes per day; former:
quit 10 y; former: quit 11-20 y; former: quit 20 y; current: pipe, cigar,
occasional; current or former: missing; or unknown); smoking duration (<10, 10
to <20, 20 to <30, 30 to <40, 40 y, or smoking duration unknown); ever use
of contraceptive pill (yes, no, or unknown); menopausal status (premenopausal,
postmenopausal, perimenopausal or unknown menopausal status, or surgical
postmenopausal); ever use of menopausal hormone therapy (yes, no, or
unknown); and intakes of total energy (kcal per day), red and processed meat
(g per day), fruits and vegetables (g per day), coffee (g per day), and fruit and
vegetable juice (g per day) (all continuous); and stratified by age (1-year
categories), EPIC center, and sex. Sugar-sweetened and artificially sweetened
soft drinks were mutually adjusted. Italy, Spain, and Sweden were excluded
from the sugar-sweetened and artificially sweetened soft drinks analyses
because information on type of soft drink consumption was not collected.
Median alcohol consumption was 5.4 g per day. EPIC indicates European
Prospective Investigation into Cancer and Nutrition.
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Table 3. Multivariable Associations Between Categories of Soft Drink Consumption and Mortality From Cancers,




Trend<1 Glassb per mo 1 to 4 Glassesb per mo
>1 to 6 Glassesb
per wk 1 to <2 Glassesb per d ≥2 Glassesb per d
Cancers, ICD-10 Codes C00-D48
Total soft drinks
Deaths, No. 9029 2610 4787 845 732 NA
Sexes combined 1 [Reference] 0.99 (0.95-1.04) 1.00 (0.96-1.04) 1.02 (0.95-1.10) 1.02 (0.95-1.11) .45
Men 1 [Reference] 1.01 (0.94-1.08) 1.03 (0.97-1.09) 1.01 (0.91-1.13) 1.05 (0.94-1.17) .39
Women 1 [Reference] 0.99 (0.93-1.05) 0.98 (0.93-1.03) 1.03 (0.93-1.14) 1.00 (0.89-1.11) .83
Artificially sweetened soft drinksc
Deaths, No. 9359 1246 1251 72 303
Sexes combined 1 [Reference] 0.96 (0.90-1.02) 1.00 (0.94-1.06) 0.92 (0.73-1.16) 1.10 (0.97-1.23) .23
Men 1 [Reference] 0.99 (0.89-1.09) 1.10 (0.99-1.22) 1.13 (0.76-1.66) 1.14 (0.95-1.37) .06
Women 1 [Reference] 0.95 (0.87-1.02) 0.95 (0.88-1.02) 0.83 (0.62-1.11) 1.06 (0.91-1.24) .98
Sugar-sweetened soft drinksc
Deaths, No. 7385 1797 2405 323 321 NA
Sexes combined 1 [Reference] 0.95 (0.90-1.01) 0.97 (0.92-1.02) 0.97 (0.86-1.09) 0.95 (0.84-1.06) .33
Men 1 [Reference] 1.01 (0.93-1.09) 0.99 (0.92-1.08) 0.98 (0.83-1.17) 0.97 (0.83-1.14) .69
Women 1 [Reference] 0.92 (0.85-0.98) 0.95 (0.89-1.01) 0.97 (0.83-1.14) 0.92 (0.78-1.09) .32
Circulatory Diseases, ICD-10 Codes I00-I99
Total soft drinks
Deaths, No. 4294 1272 2513 592 435 NA
Sexes combined 1 [Reference] 0.96 (0.90-1.02) 0.98 (0.93-1.03) 1.19 (1.09-1.31) 1.27 (1.14-1.40) <.001
Men 1 [Reference] 0.96 (0.88-1.05) 0.95 (0.89-1.03) 1.18 (1.05-1.33) 1.23 (1.08-1.41) <.001
Women 1 [Reference] 0.96 (0.87-1.05) 1.01 (0.94-1.10) 1.21 (1.05-1.38) 1.31 (1.11-1.54) <.001
Artificially sweetened soft drinksc
Deaths, No. 4614 531 525 27 170 NA
Sexes combined 1 [Reference] 0.91 (0.83-1.00) 1.01 (0.92-1.11) 1.02 (0.70-1.50) 1.52 (1.30-1.78) <.001
Men 1 [Reference] 0.81 (0.71-0.94) 1.00 (0.87-1.15) 0.91 (0.51-1.61) 1.53 (1.23-1.91) <.001
Women 1 [Reference] 1.00 (0.88-1.13) 1.01 (0.89-1.15) 1.13 (0.67-1.88) 1.50 (1.19-1.88) .001
Sugar-sweetened soft drinksc
Deaths, No. 3311 955 1206 220 175 NA
Sexes combined 1 [Reference] 0.97 (0.90-1.05) 0.96 (0.90-1.04) 1.06 (0.92-1.22) 1.11 (0.95-1.30) .16
Men 1 [Reference] 0.99 (0.89-1.10) 0.94 (0.85-1.04) 0.98 (0.80-1.20) 1.11 (0.91-1.35) .43
Women 1 [Reference] 0.97 (0.87-1.07) 0.99 (0.89-1.09) 1.15 (0.94-1.40) 1.11 (0.86-1.43) .20
Digestive Diseases, ICD-10 Codes K00-K93d
Total soft drinks
Deaths, No. 567 171 319 156 NA NA
Sexes combined 1 [Reference] 1.07 (0.89-1.28) 1.16 (1.00-1.34) 1.50 (1.24-1.81) NA <.001
Men 1 [Reference] 0.96 (0.74-1.25) 1.24 (1.01-1.52) 1.52 (1.17-1.96) NA .001
Women 1 [Reference] 1.17 (0.92-1.49) 1.07 (0.86-1.33) 1.45 (1.10-1.93) NA .02
Artificially sweetened soft drinksc
Deaths, No. 662 88 91 24 NA NA
Sexes combined 1 [Reference] 1.00 (0.79-1.27) 1.19 (0.95-1.50) 0.99 (0.65-1.50) NA .78
Men 1 [Reference] 1.13 (0.80-1.59) 1.23 (0.88-1.73) 1.04 (0.58-1.87) NA .74
Women 1 [Reference] 0.92 (0.67-1.27) 1.14 (0.83-1.55) 0.91 (0.51-1.64) NA .93
(continued)
Association Between Soft Drink Consumption and Mortality in Europe Original Investigation Research
jamainternalmedicine.com (Reprinted) JAMA Internal Medicine November 2019 Volume 179, Number 11 1485
Downloaded From: https://jamanetwork.com/ by a Norwegian Institute of Public Health User  on 01/14/2020
disease.1,25-27 We found that sugar-sweetened soft drinks were
positively associated with all-cause mortality, a result consis-
tent with findings from an HPFS/NHS analysis11 but inconsis-
tent with findings from smaller Singapore- and US-based
studies.10,28 We also found positive associations between con-
sumption of artificially sweetened soft drinks and all-cause
mortality, a finding consistent with results of the HPFS/NHS
and Women’s Health Initiative studies.11,12 Overall, to our
knowledge, this current study was the largest to date to inves-
tigate the associations between soft drink consumption and
mortality outcomes as well as the first comprehensive
European-based analysis.
We found nonlinear J-shaped associations for soft drink
consumption and all-cause mortality, with higher risks ob-
served at consumption levels of more than 125 mL per day (half
a glass) of artificially sweetened soft drinks and more than 225
mL per day (approximately 1 glass) of sugar-sweetened soft
drinks, and the lowest risks found from drinking 50 mL per day.
The reduced risk found at low consumption levels may be the
result of reverse causality (analogous to what has been ob-
served for alcohol consumption and all-cause mortality29-31),
driven by participants with disease symptoms reporting non-
consumption of soft drinks.
The role of BMI in the soft drink consumption and mor-
tality outcomes association is complex, with adiposity likely
a mediating and confounding factor that varies by cause of
death. In our analyses, results were unchanged between the
multivariable models with or without BMI adjustment, sug-
gesting that the observed associations may be independent of
adiposity. In support of this hypothesis, positive associations
were found between total, sugar-sweetened, and artificially
sweetened soft drinks with deaths from all causes, circula-
tory diseases, and digestive diseases among participants with
healthy weight. These results may suggest that soft drinks al-
ter mortality risk independently of adiposity, possibly be-
cause of the high glycemic index of sugar-sweetened soft
drinks,32 which elevates blood glucose levels and may in turn
lead to insulin resistance and inflammation.33,34
For sugar-sweetened soft drinks, we found a positive as-
sociation with all-cause mortality for participants who were
obese but no association for participants who were over-
weight. The lack of association among overweight partici-
pants is inconsistent with the result of an analysis of the HPFS/
NHS study, which found a positive association with all-cause
mortality among overweight adults.11 It is unclear why we ob-
served a positive association for sugar-sweetened soft drinks
among obese but not among overweight participants. We can-
not exclude the role of chance in these subgroup analyses, and
additional large-scale prospective studies are required to ex-
amine these associations further.
In cause-specific analyses, we found positive associa-
tions between artificially sweetened soft drink consumption
and deaths from circulatory diseases; these results are con-
sistent with those in the HPFS/NHS and Women’s Health Ini-
tiative analyses.11,13 These results were largely based on the
positive association between ischemic heart disease deaths and
consumption of artificially sweetened soft drinks. Reverse cau-
sality is a possible explanation for this positive association, with
unhealthy individuals at the study baseline (eg, those who were
overweight or obese; those with prediabetes) switching from
drinking sugar-sweetened to artificially sweetened soft drinks
to control their body weight. However, this association per-
sisted when deaths recorded in the first 8 years of follow-up
were excluded. In addition, positive associations between ar-
tificially sweetened soft drinks and all-cause and circulatory
diseases mortality were found among participants with healthy
weight. Possible biological mechanisms that may explain the
positive associations between artificially sweetened soft drinks
Table 3. Multivariable Associations Between Categories of Soft Drink Consumption and Mortality From Cancers,




Trend<1 Glassb per mo 1 to 4 Glassesb per mo
>1 to 6 Glassesb
per wk 1 to <2 Glassesb per d ≥2 Glassesb per d
Sugar-sweetened soft drinksc
Deaths, No. 494 133 158 80 NA NA
Sexes combined 1 [Reference] 1.05 (0.86-1.28) 1.07 (0.88-1.29) 1.59 (1.24-2.05) NA <.001
Men 1 [Reference] 0.94 (0.70-1.27) 1.09 (0.83-1.43) 1.51 (1.06-2.14) NA .02
Women 1 [Reference] 1.15 (0.88-1.50) 1.04 (0.79-1.37) 1.67 (1.16-2.41) NA .01
Abbreviations: HR, hazard ratio; ICD-10, International Statistical Classification of
Diseases and Related Health Problems, Tenth Revision; NA, not applicable.
a Multivariable Cox regression model adjusted for body mass index, calculated
as weight in kilograms divided by height in meters squared (<22, 22 to <25, 25
to <30, 30 to <35, or 35); physical activity index (inactive, moderately
inactive, moderately active, or active); educational status (none; primary
school completed; technical or professional school; secondary school; longer
education, including university; or not specified); alcohol consumption
(nonconsumer, <5, 5 to <15, 15 to <30, or 30 g per day); smoking status and
intensity (never; current: 1-15 cigarettes per day; current: 16-25 cigarettes per
day; current: 16 cigarettes per day; former: quit 10 y; former: quit 11-20 y;
former: quit 20 y; current: pipe, cigar, occasional; current or former: missing;
or unknown); smoking duration (<10, 10 to <20, 20 to <30, 30 to <40, 40 y,
or smoking duration unknown); ever use of contraceptive pill (yes, no, or
unknown); menopausal status (premenopausal, postmenopausal,
perimenopausal or unknown menopausal status, or surgical postmenopausal);
ever use of menopausal hormone therapy (yes, no, or unknown); and intakes
of total energy (kcal per day), red and processed meat (g per day), fruits and
vegetables (g per day), coffee (g per day), and fruit and vegetable juice (g per
day) (all continuous); and stratified by age (1-year categories), EPIC (European
Prospective Investigation into Cancer and Nutrition) center, and sex.
b 1 glass is equal to approximately 250 mL.
c Sugar-sweetened and artificially sweetened soft drinks were mutually
adjusted. Italy, Spain, and Sweden were excluded from these analyses because
information on type of soft drink consumption was not collected.
d Top 2 categories were merged as 1 glasses per day because of few cases.
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and mortality outcomes are unclear. Limited experimental evi-
dence suggests that artificial sweeteners may induce glucose
intolerance,35 but further studies are needed into the pos-
sible adverse effects of the long-term consumption of artifi-
cial sweeteners commonly used in soft drinks, such as aspar-
tame and acesulfame potassium.36
A higher level of soft drink consumption was associated
with greater risk of death from digestive diseases, with a posi-
tive association only found for sugar-sweetened soft drinks.
Hyperglycemia resulting from consumption of sugar-
sweetened soft drinks may alter gut-barrier function and in-
crease the risk of enteric infection.37 Furthermore, fructose,
a sugar commonly used in soft drinks, promotes liver lipogen-
esis, which can lead to nonalcoholic fatty liver disease and
lower insulin sensitivity.38-40
We observed no association between soft drink consump-
tion and overall cancer mortality. This result is consistent with
findings in most previous studies, which found little evidence
of a direct association between soft drink consumption and can-
cer risk,2 but it is inconsistent with that in the HPFS/NHS analy-
sis, which reported a positive association between sugar-
sweetened beverages and cancer mortality.11 We did observe
Table 4. Multivariable Associations Between Categories of Soft Drink Consumption and Mortality From Cause-Specific Cancer,







1 to 4 Glassesb
per mo
>1 to 6 Glassesb
per wk ≥1 Glassb per d
Colorectal Cancer, ICD-10 Codes C18-C20 (No. of Deaths = 2095)c
Total soft drinks 1 [Reference] 1.00 (0.87-1.14) 1.05 (0.94-1.18) 1.25 (1.07-1.47) .004
Artificially sweetened soft drinksd 1 [Reference] 1.08 (0.91-1.28) 1.02 (0.85-1.22) 1.22 (0.91-1.64) .21
Sugar-sweetened soft drinksd 1 [Reference] 0.95 (0.81-1.11) 1.00 (0.86-1.15) 1.10 (0.86-1.40) .41
Breast Cancer, ICD-10 Code C50 (No. of Deaths = 1402)c
Total soft drinks 1 [Reference] 0.95 (0.80-1.12) 0.98 (0.85-1.13) 1.13 (0.92-1.39) .20
Artificially sweetened soft drinksd 1 [Reference] 0.79 (0.63-0.98) 0.90 (0.74-1.10) 0.85 (0.59-1.22) .38
Sugar-sweetened soft drinksd 1 [Reference] 0.87 (0.71-1.06) 1.07 (0.90-1.27) 1.21 (0.91-1.62) .10
Prostate Cancer, ICD-10 Code C61 (No. of Deaths = 907)c
Total soft drinks 1 [Reference] 1.03 (0.85-1.25) 1.03 (0.88-1.22) 0.97 (0.77-1.24) .80
Artificially sweetened soft drinksd 1 [Reference] 1.23 (0.95-1.60) 1.36 (1.05-1.78) 1.05 (0.64-1.75) .53
Sugar-sweetened soft drinksd 1 [Reference] 1.14 (0.91-1.42) 1.05 (0.84-1.32) 1.08 (0.77-1.51) .76
Cerebrovascular Diseases, ICD-10 Codes I60-I69 (No. of Deaths = 2380)c
Total soft drinks 1 [Reference] 1.00 (0.88-1.13) 0.97 (0.87-1.08) 1.30 (1.12-1.50) <.001
Artificially sweetened soft drinksd 1 [Reference] 0.85 (0.71-1.03) 1.06 (0.89-1.27) 1.24 (0.91-1.70) .12
Sugar-sweetened soft drinksd 1 [Reference] 0.97 (0.84-1.12) 0.99 (0.87-1.14) 1.19 (0.97-1.47) .10
Ischemic Heart Disease, ICD-10 Codes I20-I25 (No. of Deaths = 3536)c
Total soft drinks 1 [Reference] 0.94 (0.84-1.04) 0.99 (0.91-1.07) 1.19 (1.06-1.33) .001
Artificially sweetened soft drinksd 1 [Reference] 0.89 (0.76-1.04) 1.06 (0.91-1.23) 1.41 (1.11-1.79) .003
Sugar-sweetened soft drinksd 1 [Reference] 1.03 (0.91-1.16) 0.95 (0.85-1.07) 1.04 (0.87-1.23) .84
Parkinson Disease, ICD-10 Code G20 (No. of Deaths = 254)c
Total soft drinks 1 [Reference] 0.90 (0.60-1.33) 0.81 (0.58-1.14) 1.59 (1.07-2.36) .02
Artificially sweetened soft drinksd 1 [Reference] 0.84 (0.48-1.49) 1.23 (0.73-2.06) 1.50 (0.64-3.48) .27
Sugar-sweetened soft drinksd 1 [Reference] 0.91 (0.59-1.43) 0.90 (0.58-1.39) 1.39 (0.79-2.43) .25
Alzheimer Disease, ICD-10 Code G30 (No. of Deaths = 453)c
Total soft drinks 1 [Reference] 1.23 (0.93-1.62) 1.13 (0.89-1.44) 0.82 (0.53-1.26) .33
Artificially sweetened soft drinksd 1 [Reference] 0.94 (0.57-1.55) 1.20 (0.72-1.98) 0.57 (0.14-2.33) .59
Sugar-sweetened soft drinksd 1 [Reference] 1.11 (0.75-1.65) 1.35 (0.94-1.96) 0.90 (0.44-1.81) .99
Abbreviations: HR, hazard ratio; ICD-10, International Statistical Classification of
Diseases and Related Health Problems, Tenth Revision.
a Multivariable Cox regression model adjusted for body mass index, calculated
as weight in kilograms divided by height in meters squared (<22, 22 to <25, 25
to <30, 30 to <35, or 35); physical activity index (inactive, moderately
inactive, moderately active, or active); educational status (none; primary
school completed; technical or professional school; secondary school; longer
education, including university; or not specified); alcohol consumption
(nonconsumer, <5, 5 to <15, 15 to <30, or 30 g per day); smoking status and
intensity (never; current: 1-15 cigarettes per day; current: 16-25 cigarettes per
day; current: 16 cigarettes per day; former: quit 10 y; former: quit 11-20 y;
former: quit 20 y; current: pipe, cigar, occasional; current or former: missing;
or unknown); smoking duration (<10, 10 to <20, 20 to <30, 30 to <40, 40 y,
or smoking duration unknown); ever use of contraceptive pill (yes, no, or
unknown); menopausal status (premenopausal, postmenopausal,
perimenopausal or unknown menopausal status, or surgical postmenopausal);
ever use of menopausal hormone therapy (yes, no, or unknown); and intakes
of total energy (kcal per day), red and processed meat (g per day), fruits and
vegetables (g per day), coffee (g per day), and fruit and vegetable juice (g per
day) (all continuous); and stratified by age (1-year categories), EPIC (European
Prospective Investigation into Cancer and Nutrition) center, and sex.
b One glass is equal to approximately 250 mL.
c Number of deaths based on total soft drink consumption models.
d Sugar-sweetened and artificially sweetened soft drinks were mutually
adjusted. Italy, Spain, and Sweden were excluded from these analyses because
information on type of soft drink consumption was not collected.
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a positive association between total soft drink consumption and
risk of colorectal cancer mortality, but our analyses could not
ascertain whether sugar-sweetened or artificially sweetened soft
drinks were factors in this association. In the HPFS/NHS analy-
sis, a borderline positive association was observed between
sugar-sweetened beverages and colon cancer mortality.11 Fur-
ther studies into soft drinks and cancer are warranted to iden-
tify whether direct or indirect (through weight gain or over-
weight or obesity status, which are strong risk factors for
multiple cancers41) associations exist for various cancer types.
In addition, we observed that a higher level of total soft
drink consumption was associated with greater risk of Parkin-
son disease mortality, with positive nonsignificant associa-
tions found for sugar-sweetened and artificially sweetened soft
drinks. To our knowledge, this study is the first to link soft drink
consumption with Parkinson disease, and additional studies
are required to examine this association.
Limitations
To our knowledge, this study is the largest to date to investi-
gate the association between soft drink consumption and mor-
tality. However, it has several limitations. Given the observa-
tional design of the study, it is not possible to establish causality
between soft drink consumption and mortality, and we recog-
nize that the observed associations may be biased because of
residual confounding. However, the large number of partici-
pants and recorded deaths (approximately 42 000) allowed us
to conduct analyses by subgroups of other mortality risk fac-
tors, and we generally observed similar associations across sub-
groups of considered risk factors. Furthermore, the negative con-
trol analysis found no association between consumption of soft
drinks and deaths from external causes. This study was also
limited by a single assessment of soft drink consumption at
baseline.
Conclusions
In this study, the high level of consumption of total, sugar-
sweetened, and artificially sweetened soft drinks was associ-
ated with elevated risks of death from all causes. Positive as-
sociations were observed between sugar-sweetened soft drinks
and digestive disease deaths as well as between artificially
sweetened soft drinks and circulatory disease deaths. Fur-
ther studies are needed to investigate the possible adverse
health effects of artificial sweeteners. The results of this study
are supportive of ongoing public health campaigns aimed at
reducing the consumption of soft drinks.
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